Although prolonged periods of neutropenia are common following induction and intensification of chemotherapy, this study showed that pediatric patients with AML can be safely managed in the outpatient setting after resolution of neutropenia.
AML survivors treated with blood or marrow transplantation have a greater risk of grade 3 or higher chronic health conditions, according to a survey that compared the long-term outcomes between survivors and their healthy siblings.
Researchers sought to determine if presence of comorbidities influences the underrepresentation of African American patients with acute myeloid leukemia in clinical trials.
Among patients treated with an acute lymphoblastic leukemia induction regimen, 72% achieved end-of-induction complete remission.
This study addressed the dearth of information on the incidence of psychiatric disorders related to corticosteroid-containing treatment in patients with hematologic malignancies.